B-Cell Lymphoma

This is a type of lymphoma that starts in B-cells, which are a type of white blood cell. It's a group of different diseases, meaning they can behave differently. Think of it like different kinds of cancer that start in the same type of cell.

Condition

What people with B-Cell Lymphoma report

Every report comes from a Lived member, sent anonymously.

Have you tried Rituximab for B-Cell Lymphoma?

NameHow it went

About B-Cell Lymphoma

What It Is

B-cell lymphoma is a cancer that starts in B cells, the white blood cells that normally make antibodies to fight infection. B cells live mainly in the lymph system, which includes the lymph nodes, spleen and bone marrow, so the disease most often shows up as lymph nodes that swell without pain, typically in the neck, armpit or groin. It can also start in or spread to other organs, such as the stomach, intestines, skin or brain. B-cell lymphomas make up about 85% of non-Hodgkin lymphomas in the United States. The name covers many different cancers rather than one disease, and the specific type matters more than the umbrella label. Some, such as follicular lymphoma, are slow-growing (indolent): they may cause few symptoms for years and are usually controlled rather than cured. Others, such as diffuse large B-cell lymphoma (DLBCL), the most common type, are fast-growing (aggressive): they need prompt treatment but are often curable. Besides swollen nodes, people may notice tiredness, itchy skin or a set of symptoms doctors call B symptoms: unexplained fever, drenching night sweats and weight loss. B-cell lymphoma is distinct from Hodgkin lymphoma and from lymphomas that start in T cells.

Causes & Risk Factors

In most people, doctors cannot identify why lymphoma developed. It begins when a B cell becomes abnormal and keeps dividing, building up abnormal cells in the lymph nodes or other tissues. Risk rises with age, and non-Hodgkin lymphoma is somewhat more common in men. The clearest risk factor is a weakened immune system, whether from HIV, an inherited immune disorder or medicines that suppress immunity after an organ transplant. Some autoimmune diseases, including rheumatoid arthritis and Sjögren syndrome, are also linked to higher risk. Certain infections are tied to particular types: Epstein-Barr virus (the virus behind mono) to Burkitt lymphoma and many lymphomas after transplant, Helicobacter pylori (a stomach bacterium that also causes ulcers) to MALT lymphoma (lymphoma of mucosa-associated lymphoid tissue) of the stomach, and hepatitis C to some marginal zone lymphomas. Having a risk factor does not mean someone will develop lymphoma, and many people diagnosed with it have no known risk factor.

How It's Diagnosed

Swollen lymph nodes are far more often caused by infection than by cancer, so lymphoma becomes a concern when a node keeps growing or does not go away, or when B symptoms appear. The diagnosis can only be confirmed with a biopsy: removing all or part of a lymph node, or a sample of other affected tissue, so a pathologist can examine it under a microscope. Lab tests on the sample check for markers on the cells, such as CD20 (a protein on B cells that several antibody treatments target), and for chromosome changes. Together these identify the exact type, which shapes every later decision. Once lymphoma is confirmed, staging shows how far it has spread. A PET scan, in which an injected sugar tracer collects in active lymphoma, is usually combined with a CT scan. Stage I means lymphoma in one group of lymph nodes or one area; stage IV means it has spread widely into organs outside the lymph system, such as the liver, lungs or bone marrow. Some people also need a bone marrow biopsy or a sample of spinal fluid. Blood tests check blood counts, organ function and lactate dehydrogenase (LDH), an enzyme that tends to be higher when lymphoma is more active and is one of the factors used to judge outlook. Testing for hepatitis B, hepatitis C and HIV is part of the workup, because these infections affect the treatment plan; in particular, antibody treatments such as rituximab can reactivate a past hepatitis B infection, so people who have had it are monitored closely during and after treatment.

Treatment Options

Treatment depends mainly on the type of lymphoma, how fast it is growing, the stage and a person's overall health. It is best planned by a team experienced in treating lymphoma. Fast-growing types such as DLBCL are treated soon after diagnosis. The usual first treatment combines rituximab (Rituxan), a lab-made antibody that attaches to CD20 on B cells and marks them for destruction, with several chemotherapy drugs. The best-known combination is called R-CHOP, after the initials of its drugs, and is given as infusions in repeated cycles. Radiation is sometimes added for a limited or bulky area. Many people with DLBCL are cured by this first course of treatment. Burkitt lymphoma grows even faster and needs more intensive chemotherapy that starts right away. For slow-growing types such as follicular or marginal zone lymphoma that are not causing problems, doctors often recommend watchful waiting: regular checkups and scans without treatment until the lymphoma causes symptoms or starts to affect an organ. For follicular lymphoma, starting treatment before symptoms appear has not been shown to help people live longer, and it brings side effects sooner. When treatment is needed, options include radiation for disease limited to one area, and rituximab alone or with chemotherapy. MALT lymphoma of the stomach is often treated first with antibiotics that clear H. pylori, with other treatments used if the lymphoma does not respond. When lymphoma comes back or does not respond, there are more options than in the past. CAR T-cell therapy reprograms a person's own immune cells in a lab so they attack the lymphoma. Bispecific antibodies help the immune system recognize and kill lymphoma cells. Targeted pills called Bruton tyrosine kinase (BTK) inhibitors, such as ibrutinib or zanubrutinib, block a protein some lymphoma cells need to grow. A stem cell transplant is another option for some people. These options can work well but carry substantial side effects of their own, and clinical trials are a regular part of lymphoma care. During chemotherapy, the main short-term danger to plan around is infection, because treatment lowers the white blood cells that fight germs.

What to Expect

The outlook depends heavily on the type. With DLBCL, the goal of treatment is cure. In US cancer statistics, about 65 out of 100 people diagnosed with DLBCL are alive five years later after accounting for other causes of death. That figure combines all ages and stages, so age, stage, LDH level and general health shift an individual's chances considerably, and no statistic can predict one person's course. Slow-growing B-cell lymphomas usually cannot be cured, but they often respond well when treatment is needed, and many people go through cycles of monitoring, treatment and remission over many years. When a lymphoma is watched rather than treated, that choice reflects evidence that waiting does not shorten life, not a lack of options. Over time, a slow-growing lymphoma can change into a fast-growing one (transformation), which is one reason regular checkups continue. During treatment, fatigue and the need to avoid infection shape daily life: frequent hand washing, staying away from people who are sick and careful food safety all help. After treatment ends, follow-up visits continue for years to watch for relapse and for late effects of chemotherapy or radiation, which can appear months or years later. These include heart problems, nerve damage causing numbness, infertility, loss of bone density and second cancers. Knowing which late effects apply to a particular treatment helps a person and their primary care clinician watch for them.

When to Seek Help

See a doctor about a lymph node that keeps growing or does not go away, or about unexplained fever, drenching night sweats, weight loss or lasting fatigue. If a slow-growing lymphoma is being watched, contact the care team soon about a node that suddenly grows quickly or about new fever, night sweats or weight loss, since these can signal that the lymphoma is changing. During treatment, call the care team right away for a temperature of 100.5 F (38 C) or higher, chills or other signs of infection. Infections while white blood cell counts are low can become life threatening and need urgent attention, so ask before taking acetaminophen or ibuprofen, which can hide a fever. New trouble breathing or swelling of the face or arms, which can happen when lymphoma in the chest presses on the windpipe or a large vein, also needs a prompt call; breathing trouble that is severe or getting rapidly worse needs emergency care.

Questions to Ask Your Doctor

  1. 1.Exactly which type of B-cell lymphoma do I have, and is it slow-growing or fast-growing?
  2. 2.What stage is it, and what does that mean for whether and when I should start treatment?
  3. 3.Is the goal of the treatment you recommend cure or long-term control, and what side effects should I plan for?
  4. 4.Should I consider fertility preservation, a clinical trial or a second opinion at a lymphoma center before treatment starts?
  5. 5.What follow-up will I need afterward, and which late effects should we watch for?

Last reviewed • Oct 2026

Educational content, not medical advice.